Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

8 clinical studies listed.

Filters:

Epilepsies, Partial

Tundra lists 8 Epilepsies, Partial clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06550726

High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy

Patients with focal epilepsy often have diagnostic difficulties as their culprit for seizures are difficult to be picked up using conventional imaging. The current study is to investigate the utility of advanced MRI sequences on detection of subtle lesions accountable for focal epilepsy.

Gender: All

Updated: 2026-04-03

Epilepsies, Partial
NOT YET RECRUITING

NCT06534502

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

The purpose of this research is to determine the optimal dose, safety and tolerability of zonisamide oral suspension in children ages 1 month to 17 years of age who have partial-onset (focal) seizures. The study consists of four periods: a Screening Period (about 14 days), a Titration Period (8 weeks), a Maintenance Period (4 weeks), and a Follow-Up Period (1 week).

Gender: All

Ages: 1 Month - 17 Years

Updated: 2026-03-27

2 states

Seizures
Seizures, Focal
Seizure, Partial Onset
+4
ACTIVE NOT RECRUITING

NCT04309812

Transcranial Direct Current to Treat Epilepsy at Home

This is a placebo-controlled study of feasibility and potential effectiveness of transcranial direct current stimulation (tDCS) in the home environment to reduce seizures and EEG spikes.

Gender: All

Ages: 18 Years - 100 Years

Updated: 2026-02-27

1 state

Epilepsies, Partial
RECRUITING

NCT06590896

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures

Gender: All

Updated: 2025-06-03

Epilepsies, Partial
RECRUITING

NCT06967012

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

This study primarily aims to assess the efficacy and safety of zonisamide when used as an adjunctive therapy for focal epilepsy. The main questions it aims to answer are: 1. Does the frequency of epileptic seizures decrease after oral zonisamide, and does it improve cognitive function? 2. Are there any treatment-emergent adverse events associated with oral administration of zonisamide?

Gender: All

Ages: 1 Year - 14 Years

Updated: 2025-05-13

1 state

Epilepsies, Partial
Epilepsy, Tonic-Clonic
ACTIVE NOT RECRUITING

NCT05248269

Thermocoagulation in Drug Resistant Focal Epilepsy

Therapeutic thermocoagulation will be carried out in patients with drug-resistant focal epilepsy in cases where an epileptogenic zone is found and proven according to stereo-electroencephalography (SEEG) data.

Gender: All

Ages: 18 Years - 60 Years

Updated: 2024-07-23

Epilepsy
Seizures, Focal
Epilepsy Intractable
+1
RECRUITING

NCT03949478

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

This study will evaluate the effect of ibuprofen or nifedipine on post-seizure hypoperfusion and neurological deficits in patients with epilepsy. One group will receive ibuprofen, another will receive nifedipine, and anther placebo.

Gender: All

Ages: 16 Years - Any

Updated: 2024-05-09

1 state

Epilepsy
Epilepsies, Partial
NOT YET RECRUITING

NCT06374966

Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy

Patients were first observed for a 4-week baseline period, which required no medication adjustments and a seizure frequency of greater than or equal to 2 times per 4-week . After the baseline observation period, if the patients met the criteria for enrolment and there were no contraindications, zonisamide was added as an additional therapeutic drug.Clinical data were collected before the initiation of treatment, at 1 month, 3 months and 6 months after taking zonisamide respectively, with regular review of blood tests and urinary ultrasound, and imaging and electrophysiological examinations according to the clinical needs of the patient's actual condition.

Gender: All

Ages: 2 Years - Any

Updated: 2024-04-19

1 state

Epilepsies, Partial